PixoTest® POCT COVID-19 Antigen Test Covered in Mobi Health News


iXensor has recently announced that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark.

Mobi Health News and other media has covered the end-to-end fully digitalised rapid screening solution features as below:

“It comprises a palm-sized analyser, a digital health pass app, an admin app and a HIPAA-grade health management web portal. Its diagnostic solution can provide results within 15 minutes.

The analyser transmits results simultaneously to the user’s PixoHealth Pass app through an encrypted QR code. The app also keeps the user’s vaccination certification, a credential needed for cross-border travel in many countries today.

Moreover, organisations can verify the authenticity of their members’ PixoTest result through the PixoHealth Pass Admin app.

The rapid antigen test can also potentially minimise the risks of having false-negative cases compared to other rapid tests that are interpreted by human eyes.”

Find the full articles below:

Mobi Health News: Taiwanese mobile health firm gets CE mark for its COVID-19 digital point-of-care test

Med-Tech Innovation News: iXensor receives CE-IVD mark for end-to-end rapid antigen testing solution

CISION: iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies